Regulation of gene expression by HDAC3
HDAC3 对基因表达的调节
基本信息
- 批准号:10667604
- 负责人:
- 金额:$ 50.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAcetylationBindingCD8B1 geneChromatinChromatin LoopComplexDNADefectDevelopmentEnhancersEventFailureFamilyFamily memberGene ExpressionGene Expression RegulationGeneral QualifierGenesGenetic TranscriptionGenomicsHDAC3 geneHematopoieticHistone AcetylationHistone DeacetylaseHistone DeacetylationHistone H3HistonesHoloenzymesHousekeeping GeneLysineMaintenanceMediatingMediatorModificationMultienzyme ComplexesMultipotent Stem CellsMusNCOR1 geneNCOR2 geneNeighborhoodsNucleosomesPatternPositioning AttributeProcessProteinsPurinoceptorRNA BindingRNA Polymerase IIRegulationRoleSiteT-Cell DevelopmentT-LymphocyteThymocyte DevelopmentTissuesTranscription InitiationTranscription Initiation SiteTranscriptional ActivationUntranslated RNAUp-RegulationWorkWritingbasechromatin remodelinggene repressionhistone acetyltransferasemembernon-histone proteinprematurepromoterrecruitthymocytetranscription factor
项目摘要
Abstract
Differentiation of multi-potent progenitors into T cells requires an intricate interplay between transcriptional
regulators as thymocytes proceed through each stage of development. Gene expression is controlled through
regulating transcriptional activation and chromatin accessibility. Histone deacetylases (HDACs) limit chromatin
accessibility and transcription. DP thymocytes co-express all 18 HDAC family members, but whether co-
expressed HDACs have specific or overlapping functions is not well understood. Our work has demonstrated
that HDAC3 has a unique role in T cell development, which is not compensated for by any other co-expressed
HDAC family member. HDAC3 is required for DP survival and positive selection. CD2-icre HDAC3 cKO mice
have decreased numbers of DP thymocytes with a severe block in thymocyte positive selection resulting in few
SP thymocytes produced. Mechanistically, the block in positive selection in CD2-icre HDAC3 cKO mice is due
to a failure to downregulate a single gene, RORγt. Similarly, HDAC3 is required to suppress expression of the
purinergic receptor P2RX7 in DP thymocytes, and increased P2RX7 expression contributes to the defect in DP
survival in CD2-icre HDAC3 cKO mice. HDAC3 is required to inhibit premature expression of genes that direct
commitment to the CD8 lineage. Changes in gene expression and H3K27 or H3K9 histone acetylation were
restricted, rather than global, in HDAC3-deficient DP thymocytes. Genes whose expression is normally
restricted to other (non-T) hematopoietic lineages remain off in the absence of HDAC3, and housekeeping
genes are expressed at similar levels between WT and HDAC3-deficient DP thymocytes. Therefore, HDAC3
is not a generic or general modifier of gene regulation. Instead, HDAC3 has specific functions in a small set of
genes that are critical for DP survival, positive selection and CD4/CD8 lineage choice. The focus of this
proposal is to define how HDAC3 is recruited to those genes in DP thymocytes, the alterations in chromatin
which accompany HDAC3 recruitment and the binding partners critical for HDAC3 function.
抽象的
多能祖细胞分化为 T 细胞需要转录因子之间复杂的相互作用
胸腺细胞在各个发育阶段都发挥着调节作用。基因表达通过以下方式控制
调节转录激活和染色质可及性。组蛋白脱乙酰酶 (HDAC) 限制染色质
可访问性和转录。 DP 胸腺细胞共表达所有 18 个 HDAC 家族成员,但是否共表达
表达的 HDAC 具有特定或重叠的功能尚不清楚。我们的工作已经证明
HDAC3 在 T 细胞发育中具有独特的作用,这是任何其他共表达都无法弥补的
HDAC家族成员。 HDAC3 是 DP 存活和正选择所必需的。 CD2-icre HDAC3 cKO 小鼠
DP 胸腺细胞数量减少,胸腺细胞阳性选择严重受阻,导致很少
SP胸腺细胞产生。从机制上讲,CD2-icre HDAC3 cKO 小鼠中阳性选择的阻断是由于
未能下调单个基因 RORγt。类似地,HDAC3 需要抑制
DP 胸腺细胞中的嘌呤能受体 P2RX7,P2RX7 表达增加导致 DP 缺陷
CD2-icre HDAC3 cKO 小鼠的存活率。 HDAC3 需要抑制指导基因的过早表达
对 CD8 谱系的承诺。基因表达和 H3K27 或 H3K9 组蛋白乙酰化的变化
在 HDAC3 缺陷的 DP 胸腺细胞中,这种影响是有限的,而不是整体的。表达正常的基因
在缺乏 HDAC3 的情况下,仅限于其他(非 T)造血谱系的功能仍然关闭,并且内务处理
WT 和 HDAC3 缺陷的 DP 胸腺细胞之间的基因表达水平相似。因此,HDAC3
不是基因调控的通用或一般修饰剂。相反,HDAC3 在一小部分具有特定功能
对于 DP 生存、正选择和 CD4/CD8 谱系选择至关重要的基因。本次的重点
提议是定义 HDAC3 如何被招募到 DP 胸腺细胞中的那些基因,即染色质的改变
它伴随着 HDAC3 招募和对 HDAC3 功能至关重要的结合伙伴。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Virginia Smith Shapiro其他文献
Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
激活的 T 细胞和 AP-1 的核因子不足以激活 IL-2 启动子:RE/AP 上调 CD28 的必要条件。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:4.4
- 作者:
Virginia Smith Shapiro;M. Mollenauer;Arthur Weiss - 通讯作者:
Arthur Weiss
The nutrient-sensing Rag-GTPase complex in B cells controls humoral immunity via TFEB/TFE3-dependent mitochondrial fitness
B 细胞中的营养感应 Rag-GTP 酶复合物通过依赖 TFEB/TFE3 的线粒体适应性来控制体液免疫
- DOI:
10.1038/s41467-024-54344-5 - 发表时间:
2024-11-23 - 期刊:
- 影响因子:15.700
- 作者:
Xingxing Zhu;Yue Wu;Yanfeng Li;Xian Zhou;Jens O. Watzlawik;Yin Maggie Chen;Ariel L. Raybuck;Daniel D. Billadeau;Virginia Smith Shapiro;Wolfdieter Springer;Jie Sun;Mark R. Boothby;Hu Zeng - 通讯作者:
Hu Zeng
Virginia Smith Shapiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Virginia Smith Shapiro', 18)}}的其他基金
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
- 批准号:
10308083 - 财政年份:2019
- 资助金额:
$ 50.57万 - 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
- 批准号:
10529298 - 财政年份:2019
- 资助金额:
$ 50.57万 - 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
- 批准号:
9913027 - 财政年份:2019
- 资助金额:
$ 50.57万 - 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
- 批准号:
10054986 - 财政年份:2019
- 资助金额:
$ 50.57万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 50.57万 - 项目类别:














{{item.name}}会员




